位置:首页 > 蛋白库 > RHG35_CANLF
RHG35_CANLF
ID   RHG35_CANLF             Reviewed;        1500 AA.
AC   P83509;
DT   04-APR-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2003, sequence version 1.
DT   03-AUG-2022, entry version 146.
DE   RecName: Full=Rho GTPase-activating protein 35 {ECO:0000250|UniProtKB:Q9NRY4};
DE   AltName: Full=Glucocorticoid receptor DNA-binding factor 1 {ECO:0000303|PubMed:12234678};
DE   AltName: Full=Rho GAP p190A;
DE            Short=p190-A;
GN   Name=ARHGAP35 {ECO:0000250|UniProtKB:Q9NRY4};
GN   Synonyms=GRLF1 {ECO:0000250|UniProtKB:Q9NRY4},
GN   P190A {ECO:0000250|UniProtKB:Q9NRY4},
GN   p190ARHOGAP {ECO:0000250|UniProtKB:Q9NRY4};
OS   Canis lupus familiaris (Dog) (Canis familiaris).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Laurasiatheria; Carnivora; Caniformia; Canidae; Canis.
OX   NCBI_TaxID=9615 {ECO:0000312|EMBL:AAN16354.1};
RN   [1] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA], AND TISSUE SPECIFICITY.
RC   TISSUE=Retina;
RX   PubMed=12234678; DOI=10.1016/s0378-1119(02)00765-5;
RA   Zangerl B., Zhang Q., Pearce-Kelling S.E., Aguirre G.D.;
RT   "Molecular cloning, characterization and mapping of the canine
RT   glucocorticoid receptor DNA binding factor 1 (GRLF1).";
RL   Gene 294:167-176(2002).
CC   -!- FUNCTION: Rho GTPase-activating protein (GAP). Binds several acidic
CC       phospholipids which inhibits the Rho GAP activity to promote the Rac
CC       GAP activity. This binding is inhibited by phosphorylation by PRKCA (By
CC       similarity). Involved in cell differentiation as well as cell adhesion
CC       and migration, plays an important role in retinal tissue morphogenesis,
CC       neural tube fusion, midline fusion of the cerebral hemispheres and
CC       mammary gland branching morphogenesis (By similarity). Transduces
CC       signals from p21-ras to the nucleus, acting via the ras GTPase-
CC       activating protein (GAP) (By similarity). Transduces SRC-dependent
CC       signals from cell-surface adhesion molecules, such as laminin, to
CC       promote neurite outgrowth. Regulates axon outgrowth, guidance and
CC       fasciculation (By similarity). Modulates Rho GTPase-dependent F-actin
CC       polymerization, organization and assembly, is involved in polarized
CC       cell migration and in the positive regulation of ciliogenesis and cilia
CC       elongation (By similarity). During mammary gland development, is
CC       required in both the epithelial and stromal compartments for ductal
CC       outgrowth (By similarity). Represses transcription of the
CC       glucocorticoid receptor by binding to the cis-acting regulatory
CC       sequence 5'-GAGAAAAGAAACTGGAGAAACTC-3'; this function is however
CC       unclear and would need additional experimental evidences (By
CC       similarity). {ECO:0000250|UniProtKB:P81128,
CC       ECO:0000250|UniProtKB:Q91YM2, ECO:0000250|UniProtKB:Q9NRY4}.
CC   -!- SUBUNIT: Interacts with RASA1 (By similarity). Interacts with the
CC       general transcription factor GTF2I, the interaction sequesters GTF2I in
CC       the cytoplasm (By similarity). {ECO:0000250|UniProtKB:Q91YM2,
CC       ECO:0000250|UniProtKB:Q9NRY4}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, cilium basal body
CC       {ECO:0000250|UniProtKB:Q91YM2}. Cytoplasm
CC       {ECO:0000250|UniProtKB:Q91YM2}. Nucleus {ECO:0000250|UniProtKB:Q91YM2}.
CC       Cell membrane {ECO:0000250|UniProtKB:Q91YM2}. Note=In response to
CC       integrins and SDC4 and upon phosphorylation by PKC, relocalizes from
CC       the cytoplasm to regions of plasma membrane ruffling where it
CC       colocalizes with polymerized actin. {ECO:0000250|UniProtKB:Q91YM2}.
CC   -!- TISSUE SPECIFICITY: Strongly expressed in retina (photoreceptor layer)
CC       and brain. Expression is maximal in the occipital, frontal, temporal
CC       lobe and also the cerebellum. Medium expression in the medulla and also
CC       in kidney, lung, liver, heart and spleen.
CC       {ECO:0000269|PubMed:12234678}.
CC   -!- DOMAIN: N-terminal part (1-266) has GTPase activity. Required for
CC       proper cellular localization. {ECO:0000250|UniProtKB:Q91YM2}.
CC   -!- DOMAIN: The pG1 pseudoGTPase domain does not bind GTP.
CC       {ECO:0000250|UniProtKB:Q6NU25}.
CC   -!- PTM: Phosphorylation of Tyr-1106 by PTK6 promotes the association with
CC       RASA1, inactivating RHOA while activating RAS. Phosphorylation at Tyr-
CC       308 by PDGFRA inhibits binding to GTF2I (By similarity). Phosphorylated
CC       by PRKCA at Ser-1222 and Thr-1227, induces relocalization from the
CC       cytoplasm to regions of plasma membrane ruffling and prevents the
CC       binding and substrate specificity regulation by phospholipids. In
CC       brain, phosphorylated by FYN and SRC (By similarity). During focal
CC       adhesion formation, phosphorylated by MAPK1 and MAPK3 at the C-terminal
CC       region, probably at Ser-1452, Ser-1477, Thr-1481 and Ser-1484.
CC       Phosphorylation by MAPK1 and MAPK3 inhibits GAP function and localizes
CC       ARGHAP35 away from newly forming focal adhesions and stress fibers in
CC       cells spreading on fibronectin (By similarity). Phosphorylation at Ser-
CC       1477 and Thr-1481 by GSK3B requires priming by MAPK and inhibits RhoGAP
CC       activity and modulates polarized cell migration (By similarity).
CC       {ECO:0000250|UniProtKB:P81128, ECO:0000250|UniProtKB:Q91YM2,
CC       ECO:0000250|UniProtKB:Q9NRY4}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF483595; AAN16354.1; -; mRNA.
DR   EMBL; AY079157; AAL91068.1; -; Genomic_DNA.
DR   EMBL; AY079158; AAL91069.1; -; Genomic_DNA.
DR   RefSeq; NP_001003022.1; NM_001003022.1.
DR   AlphaFoldDB; P83509; -.
DR   BMRB; P83509; -.
DR   SMR; P83509; -.
DR   STRING; 9615.ENSCAFP00000036971; -.
DR   PaxDb; P83509; -.
DR   Ensembl; ENSCAFT00030013717; ENSCAFP00030011972; ENSCAFG00030007402.
DR   Ensembl; ENSCAFT00040004921; ENSCAFP00040004225; ENSCAFG00040002575.
DR   Ensembl; ENSCAFT00845005450; ENSCAFP00845004333; ENSCAFG00845003086.
DR   GeneID; 403543; -.
DR   KEGG; cfa:403543; -.
DR   CTD; 2909; -.
DR   VEuPathDB; HostDB:ENSCAFG00845003086; -.
DR   eggNOG; KOG4271; Eukaryota.
DR   GeneTree; ENSGT01030000234635; -.
DR   HOGENOM; CLU_004268_0_0_1; -.
DR   InParanoid; P83509; -.
DR   OrthoDB; 110157at2759; -.
DR   Reactome; R-CFA-416550; Sema4D mediated inhibition of cell attachment and migration.
DR   Reactome; R-CFA-8849471; PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases.
DR   Reactome; R-CFA-8980692; RHOA GTPase cycle.
DR   Reactome; R-CFA-9013026; RHOB GTPase cycle.
DR   Reactome; R-CFA-9013106; RHOC GTPase cycle.
DR   Reactome; R-CFA-9013148; CDC42 GTPase cycle.
DR   Reactome; R-CFA-9013149; RAC1 GTPase cycle.
DR   Reactome; R-CFA-9013404; RAC2 GTPase cycle.
DR   Reactome; R-CFA-9013405; RHOD GTPase cycle.
DR   Reactome; R-CFA-9013408; RHOG GTPase cycle.
DR   Reactome; R-CFA-9013409; RHOJ GTPase cycle.
DR   Reactome; R-CFA-9696264; RND3 GTPase cycle.
DR   Reactome; R-CFA-9696270; RND2 GTPase cycle.
DR   Reactome; R-CFA-9696273; RND1 GTPase cycle.
DR   Proteomes; UP000002254; Chromosome 1.
DR   GO; GO:0015629; C:actin cytoskeleton; IEA:Ensembl.
DR   GO; GO:0036064; C:ciliary basal body; ISS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005096; F:GTPase activator activity; ISS:UniProtKB.
DR   GO; GO:0003924; F:GTPase activity; IEA:InterPro.
DR   GO; GO:0005543; F:phospholipid binding; ISS:UniProtKB.
DR   GO; GO:0007411; P:axon guidance; ISS:UniProtKB.
DR   GO; GO:0007413; P:axonal fasciculation; ISS:UniProtKB.
DR   GO; GO:0043010; P:camera-type eye development; IEA:Ensembl.
DR   GO; GO:0016477; P:cell migration; ISS:UniProtKB.
DR   GO; GO:0031668; P:cellular response to extracellular stimulus; ISS:UniProtKB.
DR   GO; GO:0021955; P:central nervous system neuron axonogenesis; ISS:UniProtKB.
DR   GO; GO:0030950; P:establishment or maintenance of actin cytoskeleton polarity; ISS:UniProtKB.
DR   GO; GO:0030900; P:forebrain development; IEA:Ensembl.
DR   GO; GO:0030879; P:mammary gland development; ISS:UniProtKB.
DR   GO; GO:0035024; P:negative regulation of Rho protein signal transduction; IEA:Ensembl.
DR   GO; GO:0043116; P:negative regulation of vascular permeability; IEA:Ensembl.
DR   GO; GO:0001843; P:neural tube closure; IEA:Ensembl.
DR   GO; GO:0097485; P:neuron projection guidance; ISS:UniProtKB.
DR   GO; GO:0045724; P:positive regulation of cilium assembly; ISS:UniProtKB.
DR   GO; GO:0043547; P:positive regulation of GTPase activity; ISS:UniProtKB.
DR   GO; GO:0010976; P:positive regulation of neuron projection development; ISS:UniProtKB.
DR   GO; GO:0032956; P:regulation of actin cytoskeleton organization; ISS:UniProtKB.
DR   GO; GO:0008064; P:regulation of actin polymerization or depolymerization; ISS:UniProtKB.
DR   GO; GO:0050770; P:regulation of axonogenesis; ISS:UniProtKB.
DR   GO; GO:0008360; P:regulation of cell shape; IEA:Ensembl.
DR   GO; GO:0008361; P:regulation of cell size; IBA:GO_Central.
DR   GO; GO:0042478; P:regulation of eye photoreceptor cell development; NAS:UniProtKB.
DR   GO; GO:0007266; P:Rho protein signal transduction; IBA:GO_Central.
DR   GO; GO:0044319; P:wound healing, spreading of cells; ISS:UniProtKB.
DR   Gene3D; 1.10.10.440; -; 2.
DR   Gene3D; 1.10.555.10; -; 1.
DR   Gene3D; 3.40.50.300; -; 1.
DR   InterPro; IPR002713; FF_domain.
DR   InterPro; IPR036517; FF_domain_sf.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR039007; pG1.
DR   InterPro; IPR008936; Rho_GTPase_activation_prot.
DR   InterPro; IPR032835; RhoGAP-FF1.
DR   InterPro; IPR000198; RhoGAP_dom.
DR   InterPro; IPR045786; RhoGAP_pG1_pG2.
DR   InterPro; IPR039006; RhoGAP_pG2.
DR   InterPro; IPR001806; Small_GTPase.
DR   Pfam; PF01846; FF; 1.
DR   Pfam; PF00071; Ras; 1.
DR   Pfam; PF00620; RhoGAP; 1.
DR   Pfam; PF16512; RhoGAP-FF1; 1.
DR   Pfam; PF19518; RhoGAP_pG1_pG2; 1.
DR   SMART; SM00441; FF; 4.
DR   SMART; SM00324; RhoGAP; 1.
DR   SUPFAM; SSF48350; SSF48350; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   SUPFAM; SSF81698; SSF81698; 1.
DR   PROSITE; PS51676; FF; 4.
DR   PROSITE; PS51852; PG1; 1.
DR   PROSITE; PS51853; PG2; 1.
DR   PROSITE; PS50238; RHOGAP; 1.
PE   2: Evidence at transcript level;
KW   Cell membrane; Cell projection; Cytoplasm; Cytoskeleton; DNA-binding;
KW   GTP-binding; GTPase activation; Lipid-binding; Membrane;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Reference proteome; Repeat;
KW   Repressor; Transcription; Transcription regulation.
FT   CHAIN           1..1500
FT                   /note="Rho GTPase-activating protein 35"
FT                   /id="PRO_0000056729"
FT   DOMAIN          270..327
FT                   /note="FF 1"
FT                   /evidence="ECO:0000305"
FT   DOMAIN          368..422
FT                   /note="FF 2"
FT   DOMAIN          429..483
FT                   /note="FF 3"
FT                   /evidence="ECO:0000305"
FT   DOMAIN          485..550
FT                   /note="FF 4"
FT   DOMAIN          592..767
FT                   /note="pG1 pseudoGTPase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01199"
FT   DOMAIN          783..947
FT                   /note="pG2 pseudoGTPase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01200"
FT   DOMAIN          1250..1437
FT                   /note="Rho-GAP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00172"
FT   REGION          1..266
FT                   /note="Has GTPase activity, required for proper
FT                   localization"
FT                   /evidence="ECO:0000250|UniProtKB:Q91YM2"
FT   REGION          970..989
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1058..1090
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1125..1147
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1178..1208
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1214..1237
FT                   /note="Required for phospholipid binding and regulation of
FT                   the substrate preference"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NRY4"
FT   REGION          1444..1500
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        970..988
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1125..1140
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1183..1197
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1449..1470
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1471..1486
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         28
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NRY4"
FT   BINDING         33..37
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NRY4"
FT   BINDING         52
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NRY4"
FT   BINDING         56
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NRY4"
FT   BINDING         95..97
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NRY4"
FT   BINDING         201..203
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NRY4"
FT   BINDING         229..231
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NRY4"
FT   MOD_RES         308
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NRY4"
FT   MOD_RES         589
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NRY4"
FT   MOD_RES         770
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NRY4"
FT   MOD_RES         773
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NRY4"
FT   MOD_RES         970
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NRY4"
FT   MOD_RES         975
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NRY4"
FT   MOD_RES         985
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q91YM2"
FT   MOD_RES         1002
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NRY4"
FT   MOD_RES         1073
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NRY4"
FT   MOD_RES         1088
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NRY4"
FT   MOD_RES         1106
FT                   /note="Phosphotyrosine; by ABL2 and PTK6"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NRY4"
FT   MOD_RES         1135
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NRY4"
FT   MOD_RES         1143
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q91YM2"
FT   MOD_RES         1151
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NRY4"
FT   MOD_RES         1177
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NRY4"
FT   MOD_RES         1180
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NRY4"
FT   MOD_RES         1222
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NRY4"
FT   MOD_RES         1227
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NRY4"
FT   MOD_RES         1237
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NRY4"
FT   MOD_RES         1473
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q91YM2"
FT   MOD_RES         1477
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q91YM2"
FT   MOD_RES         1481
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q91YM2"
FT   MOD_RES         1484
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q91YM2"
SQ   SEQUENCE   1500 AA;  170428 MW;  EB3AB65FE36E2F18 CRC64;
     MMMARKQDVR IPTYNISVVG LSGTEKEKGQ CGIGKSCLCN RFVRPSADEF HLDHTSVLST
     SDFGGRVVNN DHFLYWGEVS RSLEDCVECK MHIVEQTEFI DDQTFQPHRS TALQPYIKRA
     AATKLASAEK LMYFCTDQLG LEQDFEQKQM PDGKLLIDGF LLGIDVSRGM NRNFDDQLKF
     VSNLYNQLAK TKKPIVVVLT KCDEGVERYI RDAHTFALSK KNLQVVETSA RSNVNVDLAF
     STLVQLIDKS RGKTKIIPYF EALKQQSQQI ATAKDKYEWL VSRIVKNHNE NWLSVSRKMQ
     ASPEYQDYVY LEGTQKAKKL FLQHIHRLKH EHIERRRKLY LAALPLAFEA LIPNLDEIDH
     LSCIKTKKLL ETKPEFLKWF VVLEETPWDA TSHIDNMENE RIPFDLMDTV PAEQLYEAHL
     EKLRNERKRA EMRRAFKENL ETSPFITPGK PWEEARSFIM NEDFYQWLEE SVYMDIYGKH
     QKQIIDKAKE EFQELLLEYS ELFYELELDA KPSKEKMGVI QDVLGEEQRF KALQKLQAER
     DALILKHIHF VYHPTKETCP SCPACVDAKI EHLISSRFIR PSDRNQKNSL SDPNIDRINL
     VILGKDGLAR ELANEIRALC TNDDKYVIDG KMYELSLRPI EGNVRLPVNS FQTPTFQPHG
     CLCLYNSKES LSYVVESIEK SRESTLGRRD NHLVHLPLTL ILVNKRGDTS GETLHSLIQQ
     GQQIASKLQC VFLDPASAGI GYGRNINEKQ ISQVLKGLLD SKRNLNLVSS TASIKDLADV
     DLRIVMCLMC GDPFSADDIL FPVLQSQTCK SSHCGSNNSV LLELPIGLHK KRIELSILSY
     HSSFSIRKSR LVHGYIVFYS AKRKASLAML RAFLCEVQDI IPIQLVALTD GAIDVLDNDL
     SREQLSEGEE IAQEIDGRFT SIPCSQPQHK LEIFHPFFKD VVDKKNIIEA THMYDNAAEA
     CSTTEEVFNS PRAGSPLCNS NLQDSEEDIE PPSYSLFRED TSLPSLSKDH SKLSMELEGN
     DGLSFIMSNF ESKLNNKVPP PVKPKPPVQF DITKGDLSYL DQGHRDGQRK SVSSSTWLPP
     DGFDPSDYAE PMDAVVKPRN EEENIYSVPH DSTQGKIITI RNINKAQSNG SGNGSDSEMD
     TSSLERGRKV SIVSKPVLYR TRCSRLGRFA SYRTSFSVGS DDELGPIRKK EEDQASQGYK
     GDNAVIPYET DEDPRRRNIL RSLRRNTKKP KPKPRPSITK ATWESNYFGV PLTTVVTPEK
     PIPVFIERCI EYIEATGLST EGIYRVSGNK SEMESLQRQF DQDHNLDLAE KDFTVNTVAG
     AMKSFFSELP DPLVPYNMQI DLVEAHKIND REQKLHALKE VLKKFPKENH EVFKYVISHL
     NKVSHNNKVN LMTSENLSIC FWPTLMRPDF STMDALTATR TYQTIIELFI QQCPFFFHNR
     PISEPPGATP SSPSAVASTV PFLTSTPVTS QPSPPQSPPP TPQSPMQALL PSQLQAEHTL
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024